50-63-5 Purity
BP/EP/JP
If you have any other questions or need other size, please get a quote.
Specification
Belmessieri, Dorine, et al. Journal of the American Chemical Society 133.8 (2011): 2714-2720.
This study examined the application of tetramisole hydrochloride as a chiral isothiourea-based organocatalyst in the stereoselective synthesis of lactones via intramolecular and intermolecular Michael addition-lactonization sequences.
· Intramolecular Michael addition-lactonization: In the intramolecular series, racemic conditions using Mukaiyama-type activation with DMAP or DHPB delivered the polycyclic lactone with excellent diastereocontrol (up to 99:1 dr); the isothiourea precatalyst tetramisole hydrochloride (4) provided high enantioselectivity (≈97% ee) and good diastereocontrol (≈95:5 → 99:1 dr) though initially required high loadings (50 mol %) to give useful yields; switching the activator to pivaloyl chloride allowed productive catalysis with 20 mol % tetramisole to afford the lactone in 62% yield with 99:1 dr and 97% ee, while a related isothiourea (5) was catalytically active but showed reduced stereocontrol.
· Intermolecular Michael addition-lactonization: For the more challenging intermolecular process, a chalcone acceptor failed to react under the tested conditions, but an α-keto-β,γ-unsaturated ester furnished the anti-dihydropyranone in 95:5 dr; tetramisole (4) promoted this transformation with promising selectivity (94:6 dr, 86% ee), whereas isothiourea 5 delivered higher enantiocontrol at room temperature (96:4 dr, 91% ee) and, upon cooling, up to 97% ee-additionally, catalyst 5 could be used at 2 mol% without loss of stereoselectivity, albeit with longer reaction times.
Kumar, Alok, et al. Society for Sci. Dev. in Agric. and Tech. 35-38 (2013).
A field evaluation assessed the impact of anthelmintic treatments on trematode infections and milk production in naturally infected cattle. One treatment group received NILZAN (a combined formulation of oxyclozanide + tetramisole hydrochloride, dosed at 10 mg/kg body weight orally), and two comparator groups received triclabendazole (FASINEX, 12 mg/kg p.o.) and closantel (EXINOT, 15 mg/kg p.o.). An infected, untreated group served as control. Outcomes recorded included faecal egg counts (FEC) over time and average milk yield measured before treatment and at 1, 2, 3, 4, 6 and 7 weeks post-treatment.
· Effective Parasite Clearance: The formulation achieved a 100% reduction in fecal egg counts for both Fasciola and amphistomes at 7 days post-treatment, confirming its efficacy against the target mixed infection.
· Significant Milk Yield Recovery: Following an initial slight dip in yield one week post-treatment, the milk production in the Tetramisole HCl/Oxyclozanide group showed a strong and sustained increase. Average yield rose from a pre-treatment baseline, recovering and surpassing initial levels in subsequent weeks, ultimately contributing to an overall positive production trend over the 7-week observation period.
· Positive Economic Outcome: Across the treated cohorts, the study reported a net profit of Rs. 84.24 per animal over the 7-week period. In contrast, untreated infected animals incurred a loss of Rs. 169.30 per animal over the same interval.
The molecular formula of Tetramisole hydrochloride is C11H13ClN2S.
Some synonyms for Tetramisole hydrochloride include Anthelvet, Citarin, Concurat, and Nilverm.
Tetramisole hydrochloride is classified as an irritant.
The CAS number for Tetramisole hydrochloride is 5086-74-8.
The 2D structure of Tetramisole hydrochloride is not provided in the reference.
The 3D structure of Tetramisole hydrochloride is not provided in the reference.
Some other names for Tetramisole hydrochloride include Tetramisole HCl, Citarin, Orovermol, and Spartakon.
The UNII number for Tetramisole hydrochloride is 0NDK265MCV.
The EINECS number for Tetramisole hydrochloride is 225-799-5, and the CHEBI number is 9496.
The reference does not provide the structural formula of Tetramisole hydrochloride.
Reference: [1] Patent: US4087611, 1978, A,
Reference: [1] Patent: US4087611, 1978, A,
Reference: [1] Patent: US4087611, 1978, A,
Reference: [1]Australian Journal of Chemistry,1968,vol. 21,p. 1557 - 1570
* For details of the synthesis route, please refer to the original source to ensure accuracy.
Please kindly note that our products are for research use only.
Download